Reaction Details |
| Report a problem with these data |
Target | Proteinase-activated receptor 4 |
---|
Ligand | BDBM176053 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2234808 (CHEMBL5148580) |
---|
IC50 | 0.300000±n/a nM |
---|
Citation | Priestley, ES; Banville, J; Deon, D; Dubé, L; Gagnon, M; Guy, J; Lapointe, P; Lavallée, JF; Martel, A; Plamondon, S; Rémillard, R; Ruediger, E; Tremblay, F; Posy, SL; Guarino, VR; Richter, JM; Li, J; Gupta, A; Vetrichelvan, M; Balapragalathan, TJ; Mathur, A; Hua, J; Callejo, M; Guay, J; Sum, CS; Cvijic, ME; Watson, C; Wong, P; Yang, J; Bouvier, M; Gordon, DA; Wexler, RR; Marinier, A Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4. J Med Chem65:8843-8854 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Proteinase-activated receptor 4 |
---|
Name: | Proteinase-activated receptor 4 |
Synonyms: | Coagulation factor II receptor-like 3 | F2RL3 | PAR-4 | PAR4 | PAR4_HUMAN | Proteinase-activated receptor 4 | Proteinase-activated receptor 4 (PAR4) | Thrombin receptor-like 3 |
Type: | Protein |
Mol. Mass.: | 41145.16 |
Organism: | Homo sapiens (Human) |
Description: | Q96RI0 |
Residue: | 385 |
Sequence: | MWGRLLLWPLVLGFSLSGGTQTPSVYDESGSTGGGDDSTPSILPAPRGYPGQVCANDSDT
LELPDSSRALLLGWVPTRLVPALYGLVLVVGLPANGLALWVLATQAPRLPSTMLLMNLAA
ADLLLALALPPRIAYHLRGQRWPFGEAACRLATAALYGHMYGSVLLLAAVSLDRYLALVH
PLRARALRGRRLALGLCMAAWLMAAALALPLTLQRQTFRLARSDRVLCHDALPLDAQASH
WQPAFTCLALLGCFLPLLAMLLCYGATLHTLAASGRRYGHALRLTAVVLASAVAFFVPSN
LLLLLHYSDPSPSAWGNLYGAYVPSLALSTLNSCVDPFIYYYVSAEFRDKVRAGLFQRSP
GDTVASKASAEGGSRGMGTHSSLLQ
|
|
|
BDBM176053 |
---|
n/a |
---|
Name | BDBM176053 |
Synonyms: | US10047103, 86 | US9688695, 86 |
Type | Small organic molecule |
Emp. Form. | C23H20F3N5O5S2 |
Mol. Mass. | 567.561 |
SMILES | COc1nn2cc(nc2s1)-c1cc2c(OCc3nc(sc3C(F)(F)F)N3CCOCC3)cc(OC)cc2o1 |
Structure |
|